In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: a systematic review

AH da Silva Hellwig, D Heidrich, RA Zanette… - Journal of global …, 2019 - Elsevier
Chromoblastomycosis (CBM) is a chronic granulomatous mycosis caused by dematiaceous
fungi that affects cutaneous and subcutaneous tissues. The standard antifungal drug for …

In vitro susceptibility of chromoblastomycosis agents to five antifungal drugs and to the combination of terbinafine and amphotericin B

TC Daboit, C Massotti Magagnin, D Heidrich… - Mycoses, 2014 - Wiley Online Library
Chromoblastomycosis is a chronic mycosis that affects the skin and subcutaneous tissues
caused by several genera of dematiaceous fungi. There is not a treatment of choice. Thus …

Treating chromoblastomycosis with systemic antifungals

A Bonifaz, V Paredes-Solís, A Saúl - Expert opinion on …, 2004 - Taylor & Francis
Chromoblastomycosis is a subcutaneous mycosis for which there is no treatment of choice
but rather, several treatment options, with low cure rates and many relapses. The choice of …

A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis

RA Coelho, LS Joffe, GM Alves… - PLoS …, 2020 - journals.plos.org
Chromoblastomycosis (CBM) is a chronic subcutaneous mycosis caused by traumatic
implantation of many species of black fungi. Due to the refractoriness of some cases and …

Repurposing benzimidazoles against causative agents of Chromoblastomycosis: albendazole has superior in vitro activity than mebendazole and thiabendazole

RA Coelho, MHG Figueiredo-Carvalho… - Journal of Fungi, 2023 - mdpi.com
Chromoblastomycosis (CBM) is a neglected human implantation mycosis caused by several
dematiaceous fungal species. Currently available therapy is usually associated with …

Effect of melanin biosynthesis inhibition on the antifungal susceptibility of chromoblastomycosis agents

D Heidrich, DM Pagani, A Koehler… - Antimicrobial Agents …, 2021 - Am Soc Microbiol
Chromoblastomycosis (CBM) is a chronic subcutaneous infection caused by genera of
melanized fungi: Fonsecaea, Cladophialophora, Phialophora, Exophiala, and …

Chromoblastomycosis: still a therapeutic challenge

LGM Castro, TS De Andrade - Expert Review of Dermatology, 2010 - Taylor & Francis
Chromoblastomycosis is a chronic cutaneous and subcutaneous infection caused by the
traumatic implantation of certain dematiaceous fungi (presently classified among the …

Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment

F Queiroz-Telles, P Esterre, M Perez-Blanco… - Medical …, 2009 - academic.oup.com
Chromoblastomycosis is one of the most frequent infections caused by melanized fungi. It is
a subcutaneous fungal infection, usually an occupational related disease, mainly affecting …

[PDF][PDF] Treatment of chromoblastomycosis with itraconazole

A Restrepo, A Gonzalez, I Gomez, M Arango… - Ann NY Acad …, 1988 - academia.edu
RESULTS To date, 18 patients have been entered into the study, 3 of whom have failed to
return for their control trials (dropouts) and 5 of whom are still undergoing treatment. This …

Treatment responses in patients with chromoblastomycosis to itraconazole in Madagascar

FA Sendrasoa, VT Ratovonjanahary… - Medical …, 2022 - academic.oup.com
Introduction Chromoblastomycosis (CBM) is a chronic fungal infection of the skin and
subcutaneous tissue caused by several pigmented fungi. It is frequently found in tropical and …